Journal profile · PHARMACOLOGY & PHARMACY
RSC Pharmaceutics
ISSN 2976-8713
RSC Pharmaceutics: impact factor 5.5 (journal website); fully open access; APC charged, amount not published; median 110 days to acceptance (23 articles, last 24 months); 136 articles in 2025; indexed in ESCI.
Scope
Aims, scope and focus
By OpenAlex counts of its recent articles, RSC Pharmaceutics's largest topics are Nanoparticle-Based Drug Delivery, Advanced Drug Delivery Systems and Drug Solubulity and Delivery Systems, together about 33.5% of its articles. Its main subfields are Pharmaceutical Science. (generated from OpenAlex topic counts and CAS ranking data)
RSC Pharmaceutics is a new gold open access journal leading the way in the field of Pharmaceutics. This journal publishes research focused on formulating a drug into a medicine, with the intention of achieving controllable drug delivery with high efficacy. Research published in RSC Pharmaceutics promotes step-change science in the field of Pharmaceutics, and, as such, all submissions must show clear innovation, be scientifically sound, and have a significant impact on the field. Research sharing new scientific findings from across the areas of chemistry, materials science, biomedical sciences, pharmaceutics and drug delivery are all welcomed. Topics include but are not limited to: Formulation and design of medicinesDesign and characterization of correct dosage formsPhysicochemical and biological properties of drugs and their carriersDrug delivery devices and their mechanisms of release RSC Pharmaceutics will provide a platform for researchers to showcase their best work in this field and contribute to the advancement of Pharmaceutics. I look forward to promoting this journal and its published research to the community.Yvonne Perrie, Editor-in-Chief, RSC Pharmaceutics
From the journal's Aims & Scope
Research area (LetPub): PHARMACOLOGY & PHARMACY
Editor-in-chief Yvonne PerriePublisher website
Editorial board by country: 1 in mainland China (about 25%); most named Mainland China 1, India 1, Spain 1, Australia 1 (4 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Nanoparticle-Based Drug DeliveryMaterials Science12.3%
- Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics12.3%
- Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics8.8%
- RNA Interference and Gene DeliveryBiochemistry, Genetics and Molecular Biology8.2%
- Advancements in Transdermal Drug DeliveryPharmacology, Toxicology and Pharmaceutics6.9%
- Diverse Scientific and Economic StudiesEconomics, Econometrics and Finance6.1%
- Nanoplatforms for cancer theranosticsEngineering4.4%
- Graphene and Nanomaterials ApplicationsEngineering4.2%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Not covered
Not covered by this edition.
CAS Xinrui Journal Ranking (March 2026)Not covered
Not covered by this edition.
CAS Journal Ranking, previous upgraded edition (December 2023)Not covered
Not covered by this edition.
Database indexing
ESCIDOAJLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of ScienceScopusPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor (publisher) 2025
- 5.5Publisher website ·
- h-index
- 23OpenAlex ·
- i10-index
- 70OpenAlex ·
- 2-year mean citedness
- 6.34OpenAlex ·
- Self-citation rate
- 1.8%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 112LetPub ·
Articles by year OpenAlex count · 364 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 113 | 113 | 93 |
| 2025 | 136 | 136 | 826 |
| 2024 | 114 | 114 | 1,381 |
| 2023 | 1 | 0 | 0 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
110 daysMedian, submission to acceptance · P25–P75 63 days – 151 days
- Acceptance to online
- median 6 days (23 articles)
- Submission to online
- median 119 days
- Sample
- 23 articles with submission and acceptance dates (27 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 19 daysPublisher website ·
- Submission to publication (journal-reported)
- about 12 weeksDOAJ ·
- Peer review
- Single anonymous peer reviewDOAJ
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessDOAJ
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| DOAJ | GBP 2,200 | Yes | CC BY, CC BY-NC | |
| Publisher website | GBP 2,200 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websiteData availability, Open access, Peer review
- Data availability Data sharing
We want our authors and readers to trust the research that is published in our journals. Follow our guidance for best practice and reproducibility of experimental data, including recommended repositories. Find out more
Source ↗Publisher website ·- Open access Open access
Find out more about open access at the Royal Society of Chemistry.
Source ↗Publisher website ·- Peer review Peer review model
Single-anonymised: reviewers are anonymous and author names and affiliations are known to reviewers. Double-anonymised: both the authors’ and reviewers’ identities are anonymous (opt in at submission). Transparent: the editor’s decision letter, reviewers’ comments, and authors’ response for all versions of the manuscript are published alongside the article (opt in at any point prior to acceptance)…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- ISSN
- 2976-8713
- Official links
- Journal homepage ↗DOAJ
- Submission system ↗Publisher website
- Author guidelines ↗DOAJ
- Aims & Scope ↗DOAJ
- Special issues ↗Publisher website
- APC information ↗DOAJ
- Fee waivers ↗DOAJ
- Open access statement ↗DOAJ
- License & copyright ↗DOAJ
- Peer review process ↗DOAJ
- Editorial board ↗DOAJ
- Plagiarism policy ↗DOAJ
FAQ
Frequently asked questions about RSC Pharmaceutics
What is the impact factor of RSC Pharmaceutics?
The journal's website gives an impact factor of 5.5 (2025); this is the journal's own figure, as LetPub lists none for it; h-index 23.
How long does peer review take at RSC Pharmaceutics?
Based on the dates recorded on 23 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 110 days (interquartile range 63–151 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of RSC Pharmaceutics based?
Of the 4 board members whose country the journal's board page names, 1 (about 25%) are in mainland China; the countries named most often are Mainland China (1), India (1) and Spain (1). Counted from the institutions listed on the board page; for reference only.
Which databases index RSC Pharmaceutics?
According to LetPub and DOAJ records, RSC Pharmaceutics is indexed in ESCI and DOAJ. The journal's website also lists Web of Science and Scopus; that list has not been checked against each database.
Is RSC Pharmaceutics open access, and what is the APC?
RSC Pharmaceutics is a fully open-access journal. APC charged, amount not published.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-30). Last updated: .